The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

Guideline on Stability Testing for Active and Medicinal Products Manufactured in Climatic Zones III and IV to be Marketed in the EU - Explanatory Note on the Withdrawal of ICH Q1F

Short Title:
CPMP/ICH/421/02
Origin/Publisher:

EMEA

Document Type:
CPMP Guideline
Content:
The ICH guideline Q1F was intended to define the type and extent of stability studies required in those cases, where parts of the manufacture of the active substance or drug product were performed in climatic zone III and IV. In the meantime this guideline has been withdrawn.

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK